RecruitingNot applicableNCT07501637
Mind-Body Group Interventions for Psychological Distress in Young Breast Cancer Survivors
Sponsor: University of Alabama at Birmingham
Birmingham, AL
Breast Cancer clinical trials in Birmingham, AL
16 recruiting breast cancer studies with a site in Birmingham, AL.
RecruitingPhase 2NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Sponsor: Bayer
Birmingham, AL · +10 more sites
RecruitingPhase 2NCT06105684
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer
Sponsor: University of Alabama at Birmingham
Birmingham, AL
RecruitingPhase 1NCT07222267
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Sponsor: BeOne Medicines
Birmingham, AL · +5 more sites
RecruitingNot applicableNCT06294574
Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
Sponsor: University of Alabama at Birmingham
Birmingham, AL
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Birmingham, AL · +17 more sites
RecruitingPhase not listedNCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Sponsor: Guardant Health, Inc.
Birmingham, AL · +32 more sites
RecruitingPhase not listedNCT07211178
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Sponsor: Tempus AI
Birmingham, AL · +15 more sites
RecruitingPhase 3NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Sponsor: NRG Oncology
Birmingham, AL · +1225 more sites
RecruitingPhase 3NCT05812807
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Sponsor: Alliance for Clinical Trials in Oncology
Birmingham, AL · Fairhope, AL · Mobile, AL · +825 more sites
RecruitingPhase 1NCT06562192
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Sponsor: Novartis Pharmaceuticals
Birmingham, AL · +8 more sites
RecruitingPhase 2NCT05467891
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Sponsor: Oana Danciu
Birmingham, AL · +20 more sites
RecruitingPhase 3NCT04852887
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Sponsor: NRG Oncology
Birmingham, AL · Mobile, AL · +810 more sites
RecruitingPhase 2NCT06099769
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Birmingham, AL · +11 more sites
RecruitingPhase 2NCT05693766
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Sponsor: Sonya Reid
Birmingham, AL · +2 more sites
RecruitingPhase 3NCT05929768
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Sponsor: SWOG Cancer Research Network
Birmingham, AL · +954 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.